
Trever Bivona
Assistant Professor in Residence · University of California (San Francisco) School of Medicine
Credentials: · · · · ·
History
- 2007–2009

Research
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Cell · 2018 · 2,489 citations
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Nature Genetics · 2012 · Last of 30 authors · 1,040 citations
Understanding and targeting resistance mechanisms in NSCLC
Review · Nature reviews. Cancer · 2017 · 774 citations

30 papers · 1 as a fellow

21 papers · 1 as a resident
- AS
14 papers · 6 as a fellow

14 papers

14 papers · 3 as a fellow
- CM
13 papers · 1 as a fellow

12 papers · 2 as a fellow

10 papers
Grants
- 2026–2031
National Cancer Institute · R01
PI · $720K · Roswell Park Cancer Institute Corp
- 2023–2028
Dissecting the Role and Mechanism of EML4-ALK Condensates in Oncogenic Signaling and Tumor Growth
National Cancer Institute · R01
Contact PI · $2.6M · University of California, San Francisco
- 2017–2027
Bay Area & Anderson Team Against Acquired Resistance - u54 Program (Baataar-Up)
National Cancer Institute · U54
Contact PI · $11.7M · University of California, San Francisco
- 2022–2027
Bay Area Cancer Target Discovery and Development
National Cancer Institute · U01
PI · $4.8M · University of California, San Francisco
